| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/11/2001 | EP1114821A1 Benzopyrans and their use as therapeutic agents |
| 07/11/2001 | EP1114817A1 Substituted benzylamino piperidine compounds |
| 07/11/2001 | EP1114183A1 Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
| 07/11/2001 | EP1114182A1 Polymorphisms in the human vcam-1 gene, suitable for diagnosis and treatment of vcam-1 ligand mediated diseases |
| 07/11/2001 | EP1114164A1 Atp synthase subunit homolog |
| 07/11/2001 | EP1114159A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
| 07/11/2001 | EP1114156A2 Mammalian transforming growth factor beta - 9 (ztgfss9) |
| 07/11/2001 | EP1114155A2 Human gpcr proteins |
| 07/11/2001 | EP1114146A2 Human serine/threonine protein kinases |
| 07/11/2001 | EP1114053A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 07/11/2001 | EP1114051A1 INHIBITORS OF p38 |
| 07/11/2001 | EP1114049A1 3-bicycloindole compounds as 5-ht1d receptor ligands |
| 07/11/2001 | EP1114039A1 INHIBITORS OF p38 |
| 07/11/2001 | EP1114037A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 07/11/2001 | EP1114029A1 Novel compounds |
| 07/11/2001 | EP1113820A1 Expandible microparticle intracellular delivery system |
| 07/11/2001 | EP1113797A1 Treatment of persistent pain |
| 07/11/2001 | EP1113795A2 Tryptophanyl ester and their n-acyl derivatives for the prevention and treatment of diseases caused or exacerbated by oxidation processes |
| 07/11/2001 | EP1113793A1 A new composition |
| 07/11/2001 | EP1113792A1 A new composition |
| 07/11/2001 | EP0885220B1 Tropane-derivatives, their preparation and use |
| 07/11/2001 | EP0876371B1 Reverse-turn mimetics and methods relating thereto |
| 07/11/2001 | EP0876350B1 Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives |
| 07/11/2001 | EP0858328A4 Stable compositions containing n-propargyl-1-aminoindan |
| 07/11/2001 | EP0823896B1 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 07/11/2001 | EP0801651B1 Hydroxymethylimidazodiazepines and their esters |
| 07/11/2001 | EP0765323B1 4-(6-fluoro-1,2-benzisoxazolyl)-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and anxiety |
| 07/11/2001 | EP0760676B1 Materials and methods for treatment of plaquing diseases |
| 07/11/2001 | EP0725779B1 Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes |
| 07/11/2001 | EP0593516B1 Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
| 07/11/2001 | CN1303442A Method |
| 07/11/2001 | CN1303425A PNS cell lines and methods of use therefor |
| 07/11/2001 | CN1303379A 2-Aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 07/11/2001 | CN1303376A Compound with activity on muscarinic receptors |
| 07/11/2001 | CN1303373A N-Aryloxyethylamine derivatives for treatment of depression |
| 07/11/2001 | CN1303372A New heterocyclically substituted amides, their production and their use |
| 07/11/2001 | CN1303370A Prostaglandin derivative |
| 07/11/2001 | CN1303367A Nitric oxide synthase inhibitors |
| 07/11/2001 | CN1303364A Aminocyclohexyl ether compounds and uses thereof |
| 07/11/2001 | CN1303295A Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga |
| 07/11/2001 | CN1303292A 睡眠诱发剂 Sleep-inducing agent |
| 07/11/2001 | CN1303287A Opioid agonist/antagonist combinations |
| 07/11/2001 | CN1303286A Use of cabergoline in treatment of restless legs syndrome |
| 07/11/2001 | CN1303285A Microemulsion preconcentrates containing piperidine substance P antagonist |
| 07/11/2001 | CN1303283A Thienylazolylal coxyethanamines, their preparation and their application as medicaments |
| 07/11/2001 | CN1303281A Use of compounds for elevation of pyruvate dehydrogenase activity |
| 07/11/2001 | CN1303280A Stable dosage forms of fluoxetine and its enantiomers |
| 07/11/2001 | CN1302650A 'Hehe' ointment and its preparing process |
| 07/11/2001 | CN1302641A Chinese patent medicine for giving up smoking quickly and treating piles |
| 07/11/2001 | CN1302624A Chinese medicine for dropping drug and giving up addiction, made of natural plant |
| 07/11/2001 | CN1302610A Application of emodin-8-0-beta-D-glucoside |
| 07/11/2001 | CN1302608A Clonidine preparation |
| 07/11/2001 | CN1302607A Slow-releasing magnesium propylvalerate tablet and its preparing process |
| 07/11/2001 | CN1068327C 2,7-Substituted octahydro-1H-pyrido [1,2-alpha]pyrazin derivatives |
| 07/11/2001 | CN1068314C Triazole compounds and their use as dopamine -D3-ligands |
| 07/11/2001 | CN1068305C Process for preparing S(-)-2-(4-isobutyl-phenyl) with antimer of purity more than 90% |
| 07/10/2001 | US6258953 Arylacrylamide derivatives |
| 07/10/2001 | US6258948 An n-acylamino compound; antiinflammatory agents, autoimmune diseases |
| 07/10/2001 | US6258851 Metalloproteinase inhibitors |
| 07/10/2001 | US6258846 Enriching breast milk |
| 07/10/2001 | US6258842 Method for the preparation of citalopram |
| 07/10/2001 | US6258833 Enzyme inhibitors and antiinflammatory agents |
| 07/10/2001 | US6258827 Combinations for the treatment of parkinsonism containing selective NMDA antagonists |
| 07/10/2001 | US6258826 Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome |
| 07/10/2001 | US6258813 D4 receptor selectivity piperazine derivatives |
| 07/10/2001 | US6258809 6-aryloxy and arylthiopurines |
| 07/10/2001 | US6258807 Neuropathic pain and analgesics |
| 07/10/2001 | US6258800 Prodrugs of benzofuranylethyl carbamate NK1 antagonists |
| 07/10/2001 | US6258793 Modifying cardiac activity, modifying adipocyte function, treating central nervous system disorders, and treating diabetic disorders and obesity in mammals |
| 07/10/2001 | US6258790 Antisense modulation of integrin α4 expression |
| 07/10/2001 | US6258781 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| 07/10/2001 | US6258578 His5 |
| 07/10/2001 | US6258562 Human antibodies that bind human TNFα |
| 07/10/2001 | US6258353 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 07/10/2001 | CA2175502C Cyclic amide derivatives |
| 07/10/2001 | CA2069608C Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation |
| 07/05/2001 | WO2001048233A1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 07/05/2001 | WO2001048232A1 A plasmid for the expression of a therapeutic gene in a tissue |
| 07/05/2001 | WO2001048020A1 Composition for inhibiting macrophage activity |
| 07/05/2001 | WO2001047946A2 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 07/05/2001 | WO2001047934A1 Isoxazolo pyrimidinones and the use thereof |
| 07/05/2001 | WO2001047933A1 New polymorphic forms of olanzapine |
| 07/05/2001 | WO2001047930A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 07/05/2001 | WO2001047929A1 Triazolotriazinones and the use thereof |
| 07/05/2001 | WO2001047928A2 Imidazo 1,3,5 triazinones and the use thereof |
| 07/05/2001 | WO2001047927A1 Compound and method for the treatment of pain |
| 07/05/2001 | WO2001047926A1 Compounds and methods for the treatment of pain |
| 07/05/2001 | WO2001047924A1 Methods and compositions for the treatment of pain |
| 07/05/2001 | WO2001047923A1 Compounds and methods for the treatment of pain |
| 07/05/2001 | WO2001047922A2 Azaindoles |
| 07/05/2001 | WO2001047921A1 Pyrimidine and triazine kinase inhibitors |
| 07/05/2001 | WO2001047920A1 Benzazole derivatives and their use as jnk modulators |
| 07/05/2001 | WO2001047919A1 Substituted oxazolidinones and their use in the field of blood coagulation |
| 07/05/2001 | WO2001047915A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047914A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047905A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047904A1 Thiazolyl amide derivatives |
| 07/05/2001 | WO2001047897A1 Cytokine, especially tnf-alpha, inhibitors |
| 07/05/2001 | WO2001047892A1 Tricyclic protein kinase inhibitors |